Updates in the Diagnostic Approach of Headache

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Purpose of Review: In this review, we summarize updates in the diagnostic approach of headaches with the aim of facilitating the distinction between primary and secondary etiology in headaches. Recent Findings: In the USA, headache is the fifth most common complaint in the emergency department, but only a minority will have a secondary etiology. Initial suspicion and diagnostic workup of secondary headache relies on a patient’s medical history due to a scarcity of validated biomarkers. A special interest group under the International Headache Society recently synthesized information on red flags (information that indicates a secondary etiology) and green flags (information that indicates a primary etiology). A systematic diagnostic approach using red flags and green flags can help reduce unnecessary testing and shift attention to patient care. Summary: Going forward, further validation of these concepts is needed to properly introduce them for clinical use.

OriginalsprogEngelsk
Artikelnummer80
TidsskriftCurrent Pain and Headache Reports
Vol/bind25
Udgave nummer12
ISSN1531-3433
DOI
StatusUdgivet - 2021

Bibliografisk note

Funding Information:
Messoud Ashina has received personal fees from AbbVie/Allergan, Amgen, Eli Lilly, Lundbeck, Novartis and Teva Pharmaceuticals. He is the principal investigator for ongoing clinical trials for AbbVie/Allergan, Amgen, and Lundbeck. He has received research grants from Lundbeck Foundation, Novo Nordisk Foundation, and Novartis. He serves as associate editor of Cephalalgia, The Journal of Headache and Pain, and Brain. He is the current President of the International Headache Society. Thien Phu Do and Nikolaj Folke la Cour Karottki report no conflicts of interest.

Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

ID: 304362989